Skip to main content
. 2021 Sep 10;70(5):799–808. doi: 10.33549/physiolres.934665

Table 3.

Dietary intake of fat in pediatric Crohn’s disease (CD) patients and controls.

Variable CD (n=26) Controls (n=16)
Total energy/per kg of body weight
(kcal) 2037 (160.1)/41.2 (2.9) 1892.5 (173.5)/38.7 (2.4)
(kJ) 8351.7 (656.4)/170.6 (11.9) 7920.6 (726.6)/161.5 (10.4)

Total fat (g) 61.8 (18.8) 58.5 (16.6)
(g/1000 kcal) 30.3 (2.4) 30.9 (2.5)
(En %) 27.3 (2.0) 28.8 (2.0)

Total SFA (g) 25.1 (9.6) 21.1 (8.9)
(g/1000 kcal) 11.3 (3.1) 12.4 (3.4)
(En %) 11.5 (4.0) 9.9 (3.6)

Total MUFA (g) 13.1 (7.4) 14.8 (8.1)
(g/1000 kcal) 6.4 (3.9) 8.8 (4.2)
(En %) 5.8 (2.1) 7.1 (2.8)

Total PUFA (g) 6.7 (1.9) 5.1 (1.6)
(g/1000 kcal) 3.3 (1.6) 3.1 (1.5)
(En %) 2.1 (1.0) 2.4 (0.8)

Total n−3 (g) 0.5 (0.3) 0.3 (0.2)

Total n−6 (g) 1.7 (1.1) 1.4 (1.0)

All differences between groups do not reach statistical significance. Absolute patient numbers for given categories are presented. Observed variables are expressed as the mean (standard error) of average daily intake. P values were calculated by Mann-Whitney U test. CD – Crohn’s disease patients, En % – as percentage of total caloric intake, SFA – Saturated Fatty Acids, MUFA Monounsaturated Fatty Acids, PUFA – Polyunsaturated Fatty Acids, NS – not significant differences (p>0.05) vs. healthy controls.